NFATc1 and TNFα expression in giant cell lesions of the jaws

Journal of Oral Pathology and Medicine

Volumn 39, Issue 3, 2010, Pages 269-274

  Amaral, Fabrício Rezende ^a   Brito, João Artur Ricieri ^a   Perdigão, Paôlla Freitas ^a   Carvalho, Vinícius Magalhães ^a   De Souza, Paulo Eduardo Alencar ^b   Gomez, Marcus Vinícius ^a   De Marco, Luiz ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Giant cell lesion; Nuclear factor of activated T cells; Osteoclastogenesis; SH3BP2; Tumor necrosis factor

Indexed keywords

TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE; CYTOSINE; GLUTAMINE; LEUCINE; METHIONINE; NFATC1 PROTEIN, HUMAN; SH3BP2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; THREONINE; THYMINE;

ARTICLE; CHROMOSOME SUBSTITUTION; CLINICAL ARTICLE; DNA FLANKING REGION; EXON; FIBROUS DYSPLASIA; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GIANT CELL TUMOR; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; JAW; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SH3BP2 GENE; BLOOD; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; GIANT CELL; GIANT CELL GRANULOMA; HETEROZYGOTE; JAW DISEASE; MUTATION; PATHOLOGY; SRC HOMOLOGY DOMAIN; ULTRASTRUCTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE; CELL NUCLEUS; CHERUBISM; CYTOSINE; EXONS; GENE EXPRESSION REGULATION; GIANT CELLS; GLUTAMINE; GRANULOMA, GIANT CELL; HETEROZYGOTE; HUMANS; JAW DISEASES; LEUCINE; METHIONINE; MUTATION; NFATC TRANSCRIPTION FACTORS; POLYMORPHISM, GENETIC; SRC HOMOLOGY DOMAINS; THREONINE; THYMINE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77249134634     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00855.x     Document Type: Article

References (30)

1. Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP. Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases. Int J Oral Maxillofac Surg 1998 17 : 94 9.
2. Carinci F, Piattelli A, Martinelli M, et al. Genetic profiling of central giant cell granuloma of the jaws. J Craniofac Surg 2005 16 : 399 407.
3. de Lange J, van den Akker HP, van den Berg H. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : 603 615.
4. Horner K. Central giant cell granuloma of the jaws: a clinico-radiological study. Clin Radiol 1989 40 : 622 626.
5. Itonaga I, Hussein I, Kudo O, et al. Cellular mechanisms of osteoclast formation and lacunar in giant cell granuloma of the jaw. J Oral Pathol Med 2003 32 : 224 231.
6. Liu B, Yu SF, Li TJ. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 2003 32 : 367 375.
7. Von Wowern N. Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 90 : 765 772.
8. Hyckel P, Berndt A, Schleier P, et al. Cherubism - new hypotheses on pathogenesis and therapeutic consequences. J Craniomaxillofac Surg 2005 33 : 61 8.
9. Kaugars GE, Niamtu J 3rd., Svirsky JA. Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors. Oral Surg Oral Med Oral Pathol 1992 73 : 369 374.
10. Bell SM, Shaw M, Jou YS, Myers RM, Knowles MA. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. Genomics 1997 44 : 163 170.
11. Ren R, Mayer BJ, Cichetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993 259 : 1157 1161.
12. Ueki Y, Tiziani V, Santanna C, et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet 2001 28 : 125 126.
13. de Lange J, van Maarle MC, van den Akker HP, Redeker EJ. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : 378 381.
14. Idowu BD, Thomas G, Frow R, Diss TC, Flanagan AM. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw. Br J Oral Maxillofac Surg 2008 46 : 229 230.
15. de Lange J, van Maarle MC, van den Akker HP, Redeker EJW. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma. Br J Oral Maxillofac Surg 2007 45 : 499 500.
16. Lietman SA, Prescott NL, Hicks DG, Westra WH, Levine MA. SH3BP2 is rarely mutated in exon 9 in giant cell lesion outside cherubism. Clin Orthop Relat Res 2007 459 : 22 7.
17. Carvalho VM, Perdigão PF, Amaral FR, Souza PE, De Marco L, Gomez RS. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell and cherubism. Oral Dis 2009 15 : 106 110.
18. Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA. Identification of a novel mutation of SH3BP2 in ceherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat 2006 27 : 717 718.
19. Lietman SA, Yin L, Levine MA. SH3BP2 is an activator of NFAT activity and osteoclastogenesis. Biochem Byophys Res Commun 2008 371 : 644 648.
20. Novack D, Faccio R. Jawing about TNF: new hope for cherubism. Cell 2007 128 : 15 7.
21. Ueki Y, Lin CI, Senoo M, et al. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 'cherubism' mice. Cell 2007 128 : 71 83.
22. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990 28 : 495 503.
23. Imai Y, Kanno K, Moriya T, et al. A missense mutation in the SH3BP2 gene on chromosome 4p 16.3 found in a case of non-familial cherubism. Cleft Palate Craniofac J 2003 40 : 632 638.
24. Hounoki H, Sugiyama E, Mohamed SG, et al. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone 2008 42 : 765 774.
25. Takayanagi H. Mechanism insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005 83 : 170 179.
26. Asagiri M, Takayanagi H. The molecular understanding osteoclast differentiation. Bone 2007 40 : 251 264.
27. Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 2005 115 : 3418 3427.
28. Foucalt I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood 2005 105 : 1106 1113.
29. Takayanagi H. The role of NFAT in osteoclast formation. Ann N Y Acad Sci 2007 1116 : 227 237.
30. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008 22 : 176 185.